Thermo Fisher Details Shareholder Dissent on Executive Pay, Announces 2026 Compensation Program Changes and CEO Retention Grant
TMO sits 27% above its 52-week low of $385.46.
Summary
Thermo Fisher Scientific disclosed that its 2025 executive compensation proposal received only 36% shareholder support, leading to significant changes in the 2026 long-term incentive program and a one-time $57.7 million CEO retention grant.
Key Events · Corporate Governance and Compliance · TMO
-
Shareholder Say-on-Pay Dissent
The 2025 advisory vote on executive compensation received only 36% shareholder support, signaling significant investor dissatisfaction with current pay practices.
-
2026 Compensation Program Overhaul
In response to shareholder feedback, the company revised its 2026 long-term incentive program to include 3-year performance metrics, increased weighting for relative TSR and ROIC, and a commitment to limit one-time equity grants.
-
CEO Retention Grant Approved
A one-time performance-based restricted stock unit award valued at $57.7 million was approved for CEO Marc N. Casper in May 2025, with cliff vesting in 2030 and deferred share delivery until 2033-2035, contingent on TSR performance.
-
Board Composition Change
Director James C. Mullen is not standing for re-election, which will reduce the board size from 12 to 11 members effective at the 2026 Annual Meeting.
Analysis · TMO · Industrial Applications And Services
This DEF 14A filing reveals that Thermo Fisher Scientific's 2025 "say-on-pay" executive compensation proposal received only 36% shareholder support, indicating significant investor dissatisfaction. In response, the Compensation Committee has implemented material changes to the 2026 long-term incentive program, including shifting to 3-year performance metrics, increasing the weighting of relative Total Shareholder Return (TSR) and Return on Invested Capital (ROIC), and committing to fewer one-time equity grants. Concurrently, the Board approved a one-time $57.7 million performance-based restricted stock unit award for CEO Marc N. Casper in May 2025, designed for retention through 2030 with deferred share delivery until 2033-2035, contingent on TSR performance. This filing highlights a notable shift in executive compensation strategy driven by direct shareholder feedback.
At the time of this filing, TMO was trading at $488.25 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $181.4B. The 52-week trading range was $385.46 to $643.99. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.